Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Studies by H. Mukai and co-authors describe new findings in breast cancer
February 12th, 2009
According to recent research published in the journal Breast Cancer Research and Treatment, " Evaluation of the safety and efficacy of a combination of docetaxel and doxorubicin in breast cancer patients. Evaluation and comparison of the pathological complete response (pCR) to this regimen according to various definitions in different clinical trials." "Utilize the data to propose standardization of definitions. Patients and Methods Between 1998 and 2001, 141 patients with stage II (tumor size > 3.0 cm) or III breast cancer were treated with doxorubicin 50 mg/m(2) followed by docetaxel 60 mg/m(2) (AT) on day 1. A total of 4 courses of AT were administered as...
Source: Women's Health Weekly (2009-02-12)
|
